Biktarvy
Bictegravir · Emtricitabine · Tenofovir Alafenamide
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.
- Categories
- HIV Management · Antivirals
- Active ingredients
- Bictegravir · Emtricitabine · Tenofovir Alafenamide
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg + 200mg + 25mg
This listing uses Biktarvy as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.
Prescription and consultation requirements for Biktarvy vary by destination and are determined by the fulfilment partner.
Biktarvy details
- Alternative names
- bictegravir, emtricitabine, tenofovir alafenamide
- Therapeutic class
- Integrase Inhibitor and Nucleoside Reverse Transcriptase Inhibitor Combination
- Pharmacological class
- Antiretroviral Combination
- Contraindications
- concurrent dofetilide use; hypersensitivity to any component
- Minor side effects
- diarrhoea; nausea; headache
- Moderate side effects
- insomnia; fatigue; elevated serum lipids
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Gilead Sciences
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 30°C.
- Drug interactions
- Rifampin; St. John's Wort; Antacids
- Age restrictions
- Approved for adults and children over two years.
Serious side effects
lactic acidosis, requires immediate medical attention; severe hepatomegaly with steatosis, requires immediate medical attention
Patient summary
Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.
Mechanism of action
Blocks viral integrase and reverse transcriptase activities to prevent host chromosome entry and viral generation.
Pregnancy and breastfeeding
Pregnancy: Suitability during pregnancy depends on the specific medicine and individual circumstances. Confirm with a qualified clinician or pharmacist before use. Breastfeeding: Not recommended in HIV-positive patients.
What you will receive
Biktarvy is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.
- The supplied product is a generic equivalent containing Bictegravir / Emtricitabine / Tenofovir Alafenamide, not the originator brand shown as the reference.
- The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
- Check the final product details at checkout before confirming an order.